Announcements

May 28, 2021

Drs. Eric D. Weichel & Marcus H. Colyer Co-author Article In Ophthalmology Journal on Military Combat-Related Intraocular Foreign Body Injuries

Drs. Eric D. Weichel & Marcus H. Colyer co-authored an article in a recent issue of Ophthalmology Journal on Military Combat-Related Intraocular Foreign Body Injuries. The findings—first presented at the American Academy of Ophthalmology’s Annual Meeting—documented trauma in both Operation Iraqi Freedom and Operation Enduring Freedom.

Read More

May 28, 2021

The Retina Group of Washington Announces Merger with Retina Associates

The Retina Group of Washington (RGW), the leading provider of retinal and macular care in the Washington, D.C. metropolitan area, has announced it is merging with Retina Associates (RA) effective January 1, 2019. RGW currently has 14 offices in Maryland, Virginia and the District and totals 26 full-time physicians who provide expertise in a variety […]

Read More

May 28, 2021

Dr. John R. Minarcik, who also sees Patients in the Ophthalmology Clinic at Fort Belvoir Community Hospital, Rated Top Specialty Care Provider in the Entire United States Military Health System

Dr. John R. Minarcik, who also sees patients in the Ophthalmology Clinic at Fort Belvoir Community Hospital, was rated the top Specialty Care Provider in the entire U.S. Military Health System. According to the 2017 JOES (Joint Outpatient Experience Survey) “Best of the Best” Annual Survey, he received hundreds of positive comments and received a […]

Read More

May 28, 2021

Dr. Reginald J. Sanders Serves as Guest Panelist at Vit-Buckle Society 6th Annual Meeting

Dr. Reginald J. Sanders served as a guest panelist at the recent Vit-Buckle Society 6th Annual Meeting, participating in a discussion entitled “Real World Retina.” The society provides an open forum that mentors developing vitreoretinal surgeons, nurtures innovative surgical techniques and therapeutic approaches for retinal diseases, and fosters best practices.

Read More

May 28, 2021

Dr. Daniel M. Berinstein Co-authors a SCORE2 Trial Paper—Published in a Recent Issue of JAMA Ophthalmology—of Patients Receiving Monthly Injections vs. Treat-and-Extend Regimens to Treat Retinal Vein Occlusion

Dr. Daniel M. Berinstein co-authored a SCORE2 trial paper—published in a recent issue of JAMA Ophthalmology—that looked at patients receiving monthly injections vs. treat-and-extend regimens in a study of comparative treatments for Retinal Vein Occlusion. The multi-center, prospective, randomized trial, sponsored by the National Eye Institute (NEI), compared intravitreal bevacizumab (Avastin) to aflibercept (Eylea) for the […]

Read More

May 28, 2021

Dr. Brian K. Do Brings Sub-specialty Expertise in Uveitis to RGW, Identifying and Treating Often Misdiagnosed Inflammatory and Infectious Diseases of the Eye

Uveitis is often defined as a group of inflammatory diseases that produces interocular inflammation and destroys eye tissues. Often misdiagnosed and mistreated, it frequently affects the part of the eye called the uvea–the “middle” layer that contains much of its blood vessels–but also can affect the lens, retina, optic nerve and vitreous. And until recently, […]

Read More

May 28, 2021

Joshua D. Levinson’s Research on Endophthalmitis Results In Safer Injection Techniques at Both Retina Group of Washington Offices and Clinics Throughout the United States

Since joining The Retina Group of Washington as a Fellow just a few short years ago, Dr. Joshua D. Levinson has fashioned a formidable record of published research remarkable for a younger doctor. It is his most recent work on improving the safety of intravitreal injections that is perhaps the most meaningful to date; his […]

Read More
« Previous Page

Loading ...

©All Rights Reserved. RGW 2021